Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

NCT07145502 is registered in ClinicalTrials.gov with Biocells Medical as lead sponsor.

NCT NCT07145502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes
Lead sponsor
Biocells Medical
Phase
Observational
Overall status
Active, not recruiting
Start date
September 19, 2022
Completion date
September 19, 2027
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis, early-stage panencephalitis, neuroinflammatory demyelination